造影剤の世界市場 (種類別、処置別、投与経路別、用途別、エンドユーザー別、適応疾患別)：将来予測 (2025～2030年)

造影剤市場は、2023年に36億7,000万米ドルと評価され、2024年には40億2,000万米ドルに達すると予測され、CAGR 9.75%で成長し、2030年には70億4,000万米ドルになると予測されています。

造影剤は医用画像診断に不可欠な薬剤であり、体内の構造や体液の可視性を高め、X線、MRI、CTスキャンなどの診断手順で重要な役割を果たします。この薬剤の必要性は、鮮明で詳細な画像を提供し、様々な病状の正確な診断と管理に役立つ能力に由来します。最終用途は病院、画像診断センター、専門クリニックなど多岐にわたり、放射線科、循環器科から消化器画像診断まで、さまざまな医療分野で使用されています。

造影剤市場は、慢性疾患の増加、画像技術の進歩、頻繁な画像診断を必要とする高齢者人口の増加など、いくつかの成長要因の影響を受けています。より安全で効果的な造影剤の開発、特定の医療用途をターゲットとした技術革新、画像診断技術の強化などが好機となります。企業は、医療のインフラ整備や早期診断の利点に対する意識の高まりに後押しされる新興市場の可能性を探るべきです。

しかし、同市場は、造影剤に対する副作用のリスク、規制当局の厳しい承認、高度な画像診断に伴う高コストといった課題に直面しています。これらの限界に対処するためには、薬剤の安全性プロファイルや費用対効果の高いソリューションを強化するための研究開発への投資が必要です。

イノベーションと研究開発の機会は、副作用の少ない新規の生体適合性造影剤の開発や、従来の薬剤の必要投与量を低減するイメージング技術の研究にあります。さらに、画像解析のためのAI統合を模索することで、診断精度と業務効率を向上させることができます。業界関係者は、プレシジョン・医療の動向に合わせて、個々の患者のニーズに合わせた薬剤を設計する個別化医療のアプローチに注力すべきです。課題にもかかわらず、造影剤市場は、継続的な技術と製品の進歩が将来の機会を促進し、大きな成長機会をもたらす見通しです。企業は、複雑な市場力学を巧みに操りながら、成長の可能性を活かすために、こうした動向を戦略的に把握する必要があります。

市場力学：急速に進化する造影剤市場の主要市場インサイトを公開

造影剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がんと心血管疾患の有病率の上昇
  • 高度な画像技術に対する消費者の嗜好の高まり
  • 医療インフラへの投資の急増
• 市場抑制要因
  • より安全で効果的な造影剤の研究開発に伴う高コスト
• 市場機会
  • 新しい造影剤の技術革新と開発の増加
  • 画像診断において優れた性能を発揮するナノ粒子の開発拡大
• 市場の課題
  • 造影剤による副作用の可能性による患者の安全性への懸念の高まり

ポーターのファイブフォース：造影剤市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：造影剤市場における外部からの影響の把握

外部マクロ環境要因は、造影剤市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：造影剤市場における競合情勢の把握

造影剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：造影剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、造影剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：造影剤市場における成功への道筋を描く

造影剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

当レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1. 市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2. 市場の発展度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3. 市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4. 競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5. 製品開発・イノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1. 現在の市場規模と今後の成長予測は？

2. 最高の投資機会を提供する製品、セグメント、地域はどこか？

3. 市場を形成する主な技術動向と規制の影響とは？

4. 主要ベンダーの市場シェアと競合ポジションは？

5. ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序論

第2章 分析手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんや心血管疾患の罹患率の上昇
    • 高度な画像技術に対する消費者の嗜好の高まり
    • 医療インフラへの投資の急増
  • 抑制要因
    • より安全で効果的な造影剤の研究開発にかかる高コスト
  • 機会
    • 新しい造影剤の革新と開発の増加
    • イメージング処置において優れた性能を発揮するナノ粒子の開発が進む
  • 課題
    • 造影剤に対する潜在的な副作用による患者の安全性への懸念の高まり
• 市場セグメンテーション分析
  • 種類：正確な診断法の需要によりヨウ素化造影剤の使用が増加
  • 用途：インターベンショナルラジオロジーにおける造影剤の高い採用率
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的要因
  • 経済的要因
  • 社会的要因
  • 技術的要因
  • 法的要因
  • 環境的要因

第6章 造影剤市場：種類別

• バリウムベース造影剤
• ガドリニウムベース造影剤
• ヨウ素化造影剤
• マイクロバブル造影剤

第7章 造影剤市場：処置別

• 磁気共鳴画像
• 超音波
• X線およびコンピューター断層撮影

第8章 造影剤市場：投与経路別

• 血管内投与
• 経口投与
• 直腸経路

第9章 造影剤市場：用途別

• インターベンショナルカーディオロジー
• インターベンショナルラジオロジー
• 放射線治療

第10章 造影剤市場：エンドユーザー別

• 外来手術センター
• 画像診断センター
• 病院・クリニック

第11章 造影剤市場：適応疾患別

• がん
• 心血管疾患
• 胃腸障害
• 筋骨格障害
• 腎臓疾患
• 神経疾患

第12章 南北アメリカの造影剤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋の造影剤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの造影剤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析 (2023年)
• FPNVポジショニングマトリックス (2023年)
• 競合シナリオ分析
  • フレゼニウスカビ、新しいジェネリック MRI造影剤を発表
  • イマジオン、MRI造影剤でシーメンスとの提携を拡大
  • GE医療、 MRIエージェントPixxoscan (ガドブトロール) の発売により造影剤ポートフォリオを拡大
• 戦略分析と提言

企業一覧

• Acro Lifesciences (I) Pvt. Ltd.
• Bayer AG
• Beijing Beilu Pharmaceutical Co., Ltd.
• Bracco Spa
• Covis Group
• Daiichi Sankyo Co. Ltd.
• Fuji Pharma Co. Ltd.
• GE Healthcare Co., Ltd.
• Guerbet SA
• iMAX Diagnostic Imaging Limited
• J. B. Chemicals & Pharmaceuticals Limited
• Jodas Expoim Pvt. Ltd.
• Lantheus Medical Imaging, Inc.
• M.Biotech Limited
• Miltenyi Biotec B.V. & Co. KG
• Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
• nanoPET Pharma GmbH
• SANOCHEMIA Pharmazeutika GmbH
• Spago Nanomedical AB
• Trivitron Healthcare
• Vitalquan, LLC

LIST OF FIGURES

• FIGURE 1. CONTRAST MEDIA MARKET RESEARCH PROCESS
• FIGURE 2. CONTRAST MEDIA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONTRAST MEDIA MARKET DYNAMICS
• TABLE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY BARIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GADOLINIUM-BASED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IODINATED CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MICROBUBBLE CONTRAST MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY X-RAY & COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTRAVASCULAR ROUTE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RECTAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY INTERVENTIONAL RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTRAST MEDIA MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTRAST MEDIA MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CONTRAST MEDIA MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEPHROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CONTRAST MEDIA MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 56. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 57. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. CANADA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. CHINA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. CHINA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 88. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 89. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. CHINA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. CHINA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. INDIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. INDIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 94. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. INDIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. INDIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 195. ITALY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. ITALY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 197. ITALY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 198. ITALY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. ITALY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. ITALY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 219. POLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. POLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 221. POLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 222. POLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. POLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. POLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 225. QATAR CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. QATAR CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 227. QATAR CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 228. QATAR CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. QATAR CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. QATAR CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 285. CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 286. CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

The Contrast Media Market was valued at USD 3.67 billion in 2023, expected to reach USD 4.02 billion in 2024, and is projected to grow at a CAGR of 9.75%, to USD 7.04 billion by 2030.

Contrast media, essential agents in medical imaging, enhance the visibility of structures and fluids within the body, playing a crucial role in diagnostic procedures such as X-rays, MRI, and CT scans. The necessity of these agents stems from their ability to provide clear, detailed images, aiding in the accurate diagnosis and management of various medical conditions. They find applications across diverse medical fields, from radiology and cardiology to gastrointestinal imaging, with end-use spanning hospitals, diagnostic imaging centers, and specialized clinics.

The contrast media market is influenced by several growth factors, including the increasing prevalence of chronic diseases, advancements in imaging technology, and the rising geriatric population necessitating frequent diagnostic imaging. Opportunities arise from the development of safer, more effective contrast agents and innovations targeting specific medical applications and enhanced imaging techniques. Companies should explore the potential in emerging markets, driven by healthcare infrastructure improvements and increasing awareness of early diagnosis benefits.

However, the market faces challenges such as the risk of adverse reactions to contrast media, stringent regulatory approvals, and high costs associated with advanced imaging procedures. Addressing these limitations requires investment in research and development to enhance agent safety profiles and cost-effective solutions.

Innovation and research opportunities lie in the development of novel, biocompatible contrast agents with minimal side effects, as well as the investigation of imaging techniques that reduce the required doses of traditional agents. Additionally, exploring AI integration for image analysis can improve diagnostic accuracy and operational efficiency. Industry players should focus on personalized medicine approaches, designing agents tailored to individual patient needs, aligning with the trend toward precision healthcare. Despite challenges, the contrast media market presents substantial growth prospects, with ongoing technological and product advancements driving future opportunities. Businesses must strategically align themselves with these trends to capitalize on growth potential while navigating complex market dynamics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contrast Media Market

The Contrast Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cancer and cardiovascular diseases
  • Increasing consumer preference toward advanced imaging technologies
  • Burgeoning investment in healthcare infrastructure
• Market Restraints
  • High costs associated with research and development of safer and more effective contrast agents
• Market Opportunities
  • Increasing innovations and development of new contrast agents
  • Growing development of nanoparticles offering superior performance in imaging procedures
• Market Challenges
  • Rising patient safety concerns due to potential adverse reactions to contrast agents

Porter's Five Forces: A Strategic Tool for Navigating the Contrast Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contrast Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contrast Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contrast Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contrast Media Market

A detailed market share analysis in the Contrast Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contrast Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contrast Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contrast Media Market

A strategic analysis of the Contrast Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contrast Media Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Spa, Covis Group, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare Co., Ltd., Guerbet SA, iMAX Diagnostic Imaging Limited, J. B. Chemicals & Pharmaceuticals Limited, Jodas Expoim Pvt. Ltd., Lantheus Medical Imaging, Inc., M.Biotech Limited, Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., nanoPET Pharma GmbH, SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.

Market Segmentation & Coverage

This research report categorizes the Contrast Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Barium-Based Contrast Media, Gadolinium-Based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media.
• Based on Procedure, market is studied across Magnetic Resonance Imaging, Ultrasound, and X-ray & Computed Tomography.
• Based on Route Of Administration, market is studied across Intravascular Route, Oral Route, and Rectal Route.
• Based on Application, market is studied across Interventional Cardiology, Interventional Radiology, and Radiology.
• Based on End-user, market is studied across Ambulatory Surgery Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.
• Based on Disease Indication, market is studied across Cancer, Cardiovascular Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cancer and cardiovascular diseases
    • 5.1.1.2. Increasing consumer preference toward advanced imaging technologies
    • 5.1.1.3. Burgeoning investment in healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with research and development of safer and more effective contrast agents
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing innovations and development of new contrast agents
    • 5.1.3.2. Growing development of nanoparticles offering superior performance in imaging procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Rising patient safety concerns due to potential adverse reactions to contrast agents
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Rising use of iodinated contrast media owing to the demand for accurate diagnostic modalities
  • 5.2.2. Application: High adoption of contrast media in interventional radiology
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Contrast Media Market, by Type

• 6.1. Introduction
• 6.2. Barium-Based Contrast Media
• 6.3. Gadolinium-Based Contrast Media
• 6.4. Iodinated Contrast Media
• 6.5. Microbubble Contrast Media

7. Contrast Media Market, by Procedure

• 7.1. Introduction
• 7.2. Magnetic Resonance Imaging
• 7.3. Ultrasound
• 7.4. X-ray & Computed Tomography

8. Contrast Media Market, by Route Of Administration

• 8.1. Introduction
• 8.2. Intravascular Route
• 8.3. Oral Route
• 8.4. Rectal Route

9. Contrast Media Market, by Application

• 9.1. Introduction
• 9.2. Interventional Cardiology
• 9.3. Interventional Radiology
• 9.4. Radiology

10. Contrast Media Market, by End-user

• 10.1. Introduction
• 10.2. Ambulatory Surgery Centers
• 10.3. Diagnostic Imaging Centers
• 10.4. Hospitals & Clinics

11. Contrast Media Market, by Disease Indication

• 11.1. Introduction
• 11.2. Cancer
• 11.3. Cardiovascular Disorders
• 11.4. Gastrointestinal Disorders
• 11.5. Musculoskeletal Disorders
• 11.6. Nephrological Disorders
• 11.7. Neurological Disorders

12. Americas Contrast Media Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Contrast Media Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Contrast Media Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Fresenius Kabi Debuts New Generic MRI Contrast Agent
  • 15.3.2. Imagion Expands Collaboration With Siemens On MRI Contrast Agent
  • 15.3.3. GE HealthCare Expands Contrast Media Portfolio with Launch of MRI Agent Pixxoscan (gadobutrol)
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acro Lifesciences (I) Pvt. Ltd.
• 2. Bayer AG
• 3. Beijing Beilu Pharmaceutical Co., Ltd.
• 4. Bracco Spa
• 5. Covis Group
• 6. Daiichi Sankyo Co. Ltd.
• 7. Fuji Pharma Co. Ltd.
• 8. GE Healthcare Co., Ltd.
• 9. Guerbet SA
• 10. iMAX Diagnostic Imaging Limited
• 11. J. B. Chemicals & Pharmaceuticals Limited
• 12. Jodas Expoim Pvt. Ltd.
• 13. Lantheus Medical Imaging, Inc.
• 14. M.Biotech Limited
• 15. Miltenyi Biotec B.V. & Co. KG
• 16. Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
• 17. nanoPET Pharma GmbH
• 18. SANOCHEMIA Pharmazeutika GmbH
• 19. Spago Nanomedical AB
• 20. Trivitron Healthcare
• 21. Vitalquan, LLC